Spyre Therapeutics is a clinical-stage biotechnology company specializing in the development of next-generation treatments for inflammatory bowel disease (IBD) and other immune-mediated disorders. The company leverages advanced antibody engineering, dose optimization, and strategic therapeutic combinations to create extended half-life antibodies targeting α4β7, TL1A, and IL-23, offering a distinctive approach to address unmet medical needs in the field.
Spyre Therapeutics is a clinical-stage biotech company focused on developing next-generation inflammatory bowel disease (IBD) therapies. They are seeking an Executive Medical Director of Clinical Development to lead the execution of clinical programs evaluating innovative antibody therapeutics. This role involves designing, planning, and overseeing clinical trials, collaborating across functions, and ensuring regulatory compliance.
Spyre Therapeutics is a clinical-stage biotechnology company specializing in the development of next-generation treatments for inflammatory bowel disease (IBD) and other immune-mediated disorders. The company leverages advanced antibody engineering, dose optimization, and strategic therapeutic combinations to create extended half-life antibodies targeting α4β7, TL1A, and IL-23, offering a distinctive approach to address unmet medical needs in the field.
Invivyd